Amber Tong

Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs, is set to begin trading in Hong Kong after raising HK$2.1 billion ($270 million) in an initial public offering.

Governments across Asia are tightening border screening and quarantine preparedness as health authorities work to contain a growing Ebola outbreak in central Africa.

Governments across Asia are tightening border screening and quarantine preparedness as health authorities work to contain a growing Ebola outbreak in central Africa.

Researchers have been working for decades on so-called brain-computer interfaces to help people who suffer from paralysis, blindness, hearing loss, and more, regain function.

Hangzhou Sciwind Biosciences Co. is in “deep discussions” to expand its weight-loss drug beyond China, buoyed by new clinical data that shows the therapy helped patients lose more weight than Novo Nordisk A/S’s Wegovy.

The brain has emerged as a new frontier in medical technology. Bloomberg Primer explores where the next neurotechnology advances will lead.

The designation could threaten a key revenue stream for the drug contractor and complicate research, manufacturing and supply chains for American pharmaceutical firms.

AstraZeneca Plc will pay China’s Dizal Jiangsu Pharmaceutical Co. $600 million upfront for global rights to a lung cancer drug, adding a commercial-ready treatment to its franchise amid a wave of deals from China.

President Donald Trump’s threat of 100% tariffs against generic medicines is a major expansion of a strategy he’s been using against the pharmaceutical industry since his second term began.

Generic drug tariffs could send prices soaring for millions of Americans